| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
81,001 |
73,673 |
$6.70M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
57,440 |
49,003 |
$4.27M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
17,373 |
11,725 |
$1.60M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
16,243 |
15,341 |
$1.35M |
| 80053 |
Comprehensive metabolic panel |
48,277 |
39,404 |
$1.11M |
| 70450 |
Computed tomography, head or brain; without contrast material |
9,166 |
7,806 |
$857K |
| G0257 |
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility |
2,991 |
532 |
$834K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
6,297 |
5,592 |
$802K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
6,809 |
6,336 |
$670K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
9,578 |
1,596 |
$562K |
| G0378 |
Hospital observation service, per hour |
19,866 |
8,939 |
$509K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
15,532 |
11,942 |
$298K |
| 87070 |
|
19,065 |
18,227 |
$295K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
2,476 |
2,122 |
$290K |
| 87275 |
|
32,049 |
30,508 |
$179K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,492 |
2,081 |
$174K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
1,858 |
1,648 |
$166K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,109 |
2,466 |
$154K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,499 |
2,837 |
$151K |
| 71045 |
Radiologic examination, chest; single view |
35,384 |
30,300 |
$135K |
| 80047 |
|
4,097 |
3,107 |
$105K |
| A9270 |
Non-covered item or service |
15,978 |
3,650 |
$104K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,914 |
3,563 |
$100K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,568 |
1,411 |
$99K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,611 |
3,275 |
$98K |
| 81001 |
|
28,910 |
25,446 |
$86K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
11,609 |
9,951 |
$81K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
4,585 |
1,673 |
$81K |
| 81025 |
|
8,625 |
7,969 |
$74K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
8,664 |
6,909 |
$73K |
| 85027 |
|
71,382 |
54,280 |
$70K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
30,163 |
24,601 |
$69K |
| 97163 |
|
1,640 |
1,421 |
$64K |
| 87088 |
|
12,853 |
11,860 |
$62K |
| 71046 |
Radiologic examination, chest; 2 views |
7,799 |
7,371 |
$52K |
| 84703 |
|
13,548 |
12,209 |
$50K |
| 72131 |
|
1,368 |
1,142 |
$45K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
484 |
95 |
$44K |
| 81003 |
|
15,440 |
13,971 |
$42K |
| 73564 |
|
2,231 |
1,870 |
$41K |
| 84484 |
|
20,131 |
14,506 |
$40K |
| 73130 |
|
1,851 |
1,653 |
$40K |
| 73610 |
|
1,653 |
1,492 |
$39K |
| 73630 |
|
2,064 |
1,873 |
$37K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
6,152 |
5,225 |
$36K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
24,712 |
19,264 |
$35K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
2,055 |
1,857 |
$35K |
| 12011 |
|
593 |
560 |
$35K |
| 87040 |
|
12,834 |
10,825 |
$35K |
| 73030 |
|
1,590 |
1,372 |
$31K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
360 |
305 |
$31K |
| 85610 |
|
15,008 |
12,068 |
$30K |
| 85730 |
|
13,983 |
11,343 |
$30K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
83 |
82 |
$30K |
| 97116 |
|
1,290 |
616 |
$29K |
| 70486 |
|
1,010 |
883 |
$28K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
766 |
608 |
$28K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
11,355 |
9,381 |
$28K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
2,245 |
1,750 |
$28K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,191 |
439 |
$27K |
| 84702 |
|
4,924 |
3,933 |
$27K |
| 12001 |
|
686 |
640 |
$26K |
| C1769 |
Guide wire |
1,438 |
1,095 |
$26K |
| 80076 |
|
6,295 |
5,787 |
$25K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
2,962 |
2,368 |
$25K |
| J3490 |
Unclassified drugs |
565 |
382 |
$24K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
7,291 |
5,330 |
$24K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,843 |
1,705 |
$23K |
| 74018 |
|
1,719 |
1,620 |
$23K |
| 76830 |
Ultrasound, transvaginal |
1,316 |
1,245 |
$22K |
| 87077 |
|
3,671 |
3,252 |
$22K |
| Q5105 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units |
2,778 |
273 |
$22K |
| 93458 |
|
46 |
39 |
$22K |
| 10060 |
|
340 |
319 |
$21K |
| J1644 |
Injection, heparin sodium, per 1000 units |
4,459 |
1,677 |
$21K |
| 83735 |
|
11,898 |
9,623 |
$20K |
| 70491 |
|
74 |
72 |
$20K |
| 73110 |
|
997 |
888 |
$19K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
20,832 |
15,509 |
$19K |
| 87480 |
|
2,289 |
2,135 |
$19K |
| 83605 |
|
12,166 |
9,815 |
$18K |
| 93971 |
|
1,438 |
1,191 |
$18K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,504 |
1,865 |
$15K |
| 72100 |
|
1,278 |
1,131 |
$15K |
| 86900 |
|
4,011 |
3,281 |
$15K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
11,043 |
8,904 |
$15K |
| 83690 |
|
15,819 |
13,623 |
$15K |
| 86140 |
|
7,986 |
7,242 |
$14K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
13,574 |
10,728 |
$14K |
| J7050 |
Infusion, normal saline solution, 250 cc |
5,175 |
3,584 |
$14K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,273 |
1,484 |
$13K |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
351 |
205 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
20,120 |
19,353 |
$13K |
| 97167 |
|
1,085 |
922 |
$13K |
| 74022 |
|
1,612 |
1,570 |
$13K |
| 87807 |
|
10,071 |
9,669 |
$12K |
| 73090 |
|
566 |
496 |
$12K |
| 71250 |
|
144 |
128 |
$12K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,382 |
999 |
$11K |
| 85652 |
|
2,193 |
1,880 |
$11K |
| 70496 |
|
166 |
134 |
$10K |
| 87276 |
|
32,042 |
30,504 |
$10K |
| G0330 |
Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room |
16 |
13 |
$10K |
| S0028 |
Injection, famotidine, 20 mg |
1,011 |
813 |
$10K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
164 |
137 |
$10K |
| 72128 |
|
461 |
382 |
$9K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
10,545 |
7,054 |
$9K |
| 84112 |
|
269 |
242 |
$9K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
1,287 |
993 |
$9K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
2,181 |
2,068 |
$8K |
| J2704 |
Injection, propofol, 10 mg |
628 |
476 |
$8K |
| 73080 |
|
264 |
243 |
$8K |
| J1756 |
Injection, iron sucrose, 1 mg |
517 |
265 |
$7K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
698 |
582 |
$7K |
| 82553 |
|
1,238 |
806 |
$7K |
| 96368 |
|
54 |
52 |
$7K |
| 86738 |
|
4,997 |
4,826 |
$6K |
| 73590 |
|
603 |
527 |
$6K |
| 82040 |
|
1,411 |
1,179 |
$6K |
| 76801 |
|
221 |
199 |
$6K |
| 72040 |
|
253 |
232 |
$6K |
| 72170 |
|
1,241 |
934 |
$5K |
| 82550 |
|
3,636 |
2,819 |
$5K |
| 82247 |
|
1,439 |
1,197 |
$5K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
12,266 |
11,384 |
$5K |
| 73502 |
|
469 |
409 |
$5K |
| 84155 |
|
1,412 |
1,178 |
$5K |
| 84450 |
|
1,404 |
1,170 |
$5K |
| 84460 |
|
1,400 |
1,168 |
$5K |
| 84075 |
|
1,398 |
1,170 |
$5K |
| 86901 |
|
5,065 |
4,210 |
$5K |
| 86850 |
|
2,005 |
1,574 |
$5K |
| S5010 |
5% dextrose and 0.45% normal saline, 1000 ml |
102 |
67 |
$4K |
| 83880 |
|
4,372 |
3,577 |
$4K |
| 12002 |
|
106 |
99 |
$4K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
277 |
266 |
$4K |
| 74019 |
|
410 |
388 |
$4K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
1,468 |
1,255 |
$4K |
| 74174 |
|
39 |
29 |
$4K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,630 |
1,288 |
$4K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,089 |
1,609 |
$4K |
| 84100 |
|
1,604 |
1,241 |
$4K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
387 |
285 |
$3K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
52 |
50 |
$3K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
1,889 |
1,728 |
$3K |
| 85379 |
|
2,933 |
2,586 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,494 |
2,114 |
$3K |
| 71101 |
|
44 |
41 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,353 |
1,969 |
$2K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
44 |
44 |
$2K |
| 70498 |
|
202 |
162 |
$2K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
259 |
132 |
$2K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
420 |
343 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,027 |
854 |
$2K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,425 |
3,325 |
$2K |
| 76775 |
|
56 |
51 |
$2K |
| 84132 |
|
144 |
121 |
$2K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
16 |
12 |
$1K |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
2,417 |
2,332 |
$1K |
| 97535 |
Self-care/home management training, each 15 minutes |
607 |
391 |
$1K |
| 80061 |
Lipid panel |
696 |
566 |
$1K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
54 |
40 |
$1K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
35 |
28 |
$1K |
| 82805 |
|
373 |
297 |
$1K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
1,025 |
915 |
$1K |
| 73140 |
|
27 |
25 |
$1K |
| 76870 |
|
41 |
38 |
$1K |
| 70360 |
|
69 |
68 |
$1K |
| 87510 |
|
2,229 |
2,081 |
$1K |
| J1815 |
Injection, insulin, per 5 units |
2,117 |
986 |
$864.32 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,420 |
1,184 |
$841.36 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
481 |
336 |
$820.13 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
447 |
401 |
$708.95 |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
145 |
135 |
$704.92 |
| C1760 |
Closure device, vascular (implantable/insertable) |
73 |
59 |
$696.50 |
| 99152 |
|
76 |
51 |
$696.50 |
| 82435 |
|
16 |
13 |
$662.16 |
| 82150 |
|
2,204 |
2,006 |
$629.17 |
| 36600 |
|
290 |
229 |
$621.81 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
841 |
546 |
$590.31 |
| 87660 |
|
2,229 |
2,081 |
$579.54 |
| 82248 |
|
3,469 |
2,477 |
$513.54 |
| 96376 |
|
1,078 |
915 |
$487.43 |
| 94760 |
|
327 |
299 |
$458.66 |
| 84295 |
|
16 |
13 |
$458.15 |
| 82947 |
|
16 |
13 |
$458.15 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,896 |
1,618 |
$455.60 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
2,183 |
2,068 |
$445.71 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
1,228 |
1,087 |
$434.70 |
| J2060 |
Injection, lorazepam, 2 mg |
1,537 |
1,145 |
$416.96 |
| 73060 |
|
14 |
12 |
$390.09 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
560 |
353 |
$360.00 |
| 87205 |
|
1,394 |
1,153 |
$352.66 |
| 76937 |
|
63 |
43 |
$351.20 |
| 82077 |
|
2,052 |
1,670 |
$339.87 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
409 |
282 |
$330.80 |
| 82731 |
|
33 |
27 |
$317.12 |
| 73700 |
|
16 |
14 |
$301.92 |
| 80320 |
|
1,295 |
1,130 |
$284.73 |
| 93976 |
|
56 |
53 |
$281.75 |
| 90714 |
|
679 |
602 |
$241.06 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
52 |
45 |
$233.77 |
| J3486 |
Injection, ziprasidone mesylate, 10 mg |
254 |
136 |
$196.98 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
623 |
306 |
$182.26 |
| 73120 |
|
20 |
15 |
$180.32 |
| 93970 |
|
26 |
25 |
$178.14 |
| 76857 |
|
358 |
348 |
$160.91 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
349 |
275 |
$153.34 |
| 84439 |
|
129 |
111 |
$151.02 |
| J1953 |
Injection, levetiracetam, 10 mg |
61 |
52 |
$141.66 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
75 |
56 |
$113.33 |
| G1003 |
Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program |
463 |
330 |
$88.93 |
| 87186 |
|
793 |
726 |
$84.85 |
| 82270 |
|
29 |
24 |
$76.79 |
| 80329 |
|
347 |
303 |
$67.68 |
| 82009 |
|
286 |
240 |
$39.61 |
| 80069 |
|
20 |
13 |
$27.40 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
178 |
151 |
$13.98 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,835 |
1,438 |
$9.00 |
| J0456 |
Injection, azithromycin, 500 mg |
860 |
711 |
$8.38 |
| 82570 |
|
42 |
38 |
$5.32 |
| 86923 |
|
17 |
12 |
$4.29 |
| 87340 |
|
240 |
165 |
$3.05 |
| 80143 |
|
245 |
213 |
$1.54 |
| Q0177 |
Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
58 |
53 |
$0.00 |
| 85045 |
|
258 |
202 |
$0.00 |
| 29125 |
|
48 |
48 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
224 |
163 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
70 |
65 |
$0.00 |
| 84550 |
|
92 |
85 |
$0.00 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
20 |
12 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
96 |
93 |
$0.00 |
| 83655 |
|
19 |
19 |
$0.00 |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
71 |
68 |
$0.00 |
| 84156 |
|
29 |
25 |
$0.00 |
| 85014 |
|
49 |
28 |
$0.00 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
15 |
13 |
$0.00 |
| 82140 |
|
34 |
27 |
$0.00 |
| 83615 |
|
84 |
68 |
$0.00 |
| J1630 |
Injection, haloperidol, up to 5 mg |
87 |
68 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
147 |
136 |
$0.00 |
| 85018 |
|
97 |
53 |
$0.00 |
| 82746 |
|
14 |
13 |
$0.00 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
55 |
52 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
67 |
37 |
$0.00 |
| 86593 |
|
17 |
14 |
$0.00 |
| 86317 |
|
111 |
81 |
$0.00 |
| 86308 |
|
40 |
38 |
$0.00 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
12 |
12 |
$0.00 |
| 82607 |
|
29 |
27 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
28 |
28 |
$0.00 |
| 82330 |
|
29 |
25 |
$0.00 |
| 86920 |
|
41 |
24 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
14 |
14 |
$0.00 |